[Appearance of exanthema during hing-dosage therapy with beta-lacta antibiotics].
D000667:Ampicillin / Q000008:administration & dosage / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D002228:Carbenicillin / Q000008:administration & dosage / Q000009:adverse effects; D002511:Cephalosporins / Q000008:administration & dosage / Q000009:adverse effects; D003875:Drug Eruptions / Q000209:etiology*; D004359:Drug Therapy, Combination / Q000009:adverse effects; D005076:Exanthema / Q000139:chemically induced*; D005839:Gentamicins / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D010068:Oxacillin / Q000008:administration & dosage / Q000009:adverse effects; D010400:Penicillin G / Q000008:administration & dosage / Q000009:adverse effects; D010406:Penicillins / Q000008:administration & dosage / Q000009:adverse effects; D047090:beta-Lactams / Q000008:administration & dosage / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D005839:Gentamicins; D010406:Penicillins; D047090:beta-Lactams; D000667:Ampicillin; D002228:Carbenicillin; D010400:Penicillin G; D010068:Oxacillin
Uber das Auftreten von Exanthemen unter hochdosierter Therapie mit Beta-Laktamantibiotika